NYSE: AFLAflac Inc Stock
$102.18-0.45 (-0.44%)
Updated Jun 13, 2025
AFL Price
$102.18
Fair Value Price
N/A
Market Cap
$55.24B
52 Week Low
$86.55
52 Week High
$115.50
P/E
15.94x
P/B
2.1x
P/S
3.59x
PEG
2.86x
Dividend Yield
1.55%
Revenue
$16.89B
Earnings
$3.59B
Gross Margin
56.3%
Operating Margin
27.18%
Profit Margin
21.3%
Debt to Equity
3.57
Operating Cash Flow
$2B
Beta
0.67
Next Earnings
Jul 29, 2025
Ex-Dividend
N/A
Next Dividend
N/A
AFL Overview
Aflac Incorporated provides supplemental health and life insurance products in the U.S. and Japan. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, whole and term life insurance products. The Aflac U.S. provides cancer, accident, short-term disability insurance products. It sells its products through sales associates, brokers, and agencies. Aflac was founded in 1955 and is based in Columbus, GA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine AFL's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Property & Casualty Insurance
Industry Rating
C
AFL
Ranked#19 of 19
Ranked#19 of 19
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $23.96 | B | |
| $57.04 | B | |
| $6.06 | C |
Be the first to know about important AFL news, forecast changes, insider trades & much more!
AFL News
Overview
Due Diligence Score
–
Industry Average (37)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AFL scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AFL ($102.18) is trading above its intrinsic value of $47.89, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AFL is good value based on its earnings relative to its share price (15.94x), compared to the US market average (31.36x)
P/E vs Market Valuation
AFL is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more AFL due diligence checks available for Premium users.
Valuation
AFL price to earnings (PE)
For valuing profitable companies with steady earnings
Company
15.94x
Industry
15.46x
Market
31.36x
AFL is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
AFL is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
AFL price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.1x
Industry
1.45x
AFL is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AFL price to earnings growth (PEG)
For valuing profitable companies with growth potential
AFL is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
AFL's financial health
Profit margin
Revenue
$3.4B
Net Income
$29.0M
Profit Margin
0.9%
AFL's Earnings (EBIT) of $4.59B... subscribe to Premium to read more.
Interest Coverage Financials
AFL's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$120.3B
Liabilities
$93.9B
Debt to equity
3.57
AFL's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AFL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$589.0M
Investing
-$359.0M
Financing
-$1.3B
AFL's operating cash flow ($2.45B)... subscribe to Premium to read more.
Debt Coverage Financials
AFL vs Property & Casualty Insurance Stocks
Aflac Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.